Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-04

Clinical Trial Update: Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence [NA]

View source ↗

Summary

Results from a completed clinical trial of the Adjustable Continence Therapy (ACT) device for female stress urinary incontinence have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adjustable Continence Therapy (ACT) Device (Adjustable continence therapy device)

Snippet

Sponsor: Uromedica | Conditions: Urinary Incontinence | NA | Status: COMPLETED | Results posted: 2018-06-04